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Abstract 26 
Purpose 27 
Lower fat fraction (FF) in brown adipose tissue (BAT) than white adipose tissue 28 
(WAT) has been exploited using Dixon-based Magnetic Resonance Imaging (MRI) to 29 
differentiate these tissues in rodents, human infants and adults. We aimed to 30 
determine whether an optimal FF threshold could be determined to differentiate 31 
between BAT and WAT in adult humans in vivo. 32 
Methods  33 
Sixteen volunteers were recruited (9 females, 7 males; 44.2±19.2 years) based on 34 
BAT uptake on 18F-FDG PET/CT. Axial 3-echo TSE IDEAL sequences were 35 
acquired (TR(ms)/TE(ms)/matrix/NEX/FoV(cm) = 440/10.7-11.1/512x512/3/30-40), 36 
of the neck/upper thorax on a 3T HDxt MRI scanner (GE Medical Systems, 37 
Milwaukee, USA), and FF maps generated from the resulting water- and fat-only 38 
images. BAT depots were delineated on PET/CT based on standardized uptake 39 
values (SUV) >2.5 g/ml, and transposed onto FF maps. WAT depots were defined 40 
manually within subcutaneous fat. 41 
Receiver operating characteristic (ROC) analyses were performed, and optimal 42 
thresholds for differentiating BAT and WAT determined for each subject using 43 
Youden’s J statistic. 44 
Results 45 
There was large variation in optimal FF thresholds to differentiate BAT and WAT 46 
between subjects (0.68–0.85), with great variation in sensitivity (0.26-0.84) and 47 
specificity (0.62-0.99). FF was excellent or good at separating BAT and WAT in four 48 
cases (area under the curve [AUC] 0.84-0.92), but poor in 10 (AUC 0.25-0.68). 49 
Conclusion 50 
Although this technique was effective at differentiating BAT and WAT in some cases, 51 
no universal cut-off could be identified to reliably differentiate BAT and WAT in vivo 52 
in adult humans on the basis of FF. 53 
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1. Introduction 60 
Obesity is a major global public health problem (1); the prevalence of obesity has 61 
doubled between 1980 and 2008, with approximately 1.4 billion adults being 62 
overweight (i.e. BMI > 25kg/m2), of whom 500 million are obese (i.e. BMI > 30 kg/m2) 63 
(2). 64 
Brown adipose tissue (BAT) may have a role in the aetiology and management of 65 
obesity. BAT is a thermogenic organ occurring exclusively in mammals. It produces 66 
heat through non-shivering thermogenesis by dissipating chemical energy (in the 67 
form of fatty acids and glucose) in response to cold exposure without the need for 68 
shivering or locomotor activity (3). 69 
There is compelling evidence of a link between defective BAT and obesity (4,5). In 70 
rodents, BAT dysfunction leads to impaired non-shivering thermogenesis and a 71 
propensity for obesity (6). Furthermore BAT ablation has been shown to induce 72 
obesity in mice (7). Post mortem studies in humans have shown a correlation 73 
between larger BAT accumulations and lower BMI (8). 74 
Stimulation of non-shivering thermogenesis through BAT manipulation has been 75 
posited as a means of reducing elevated triglycerides and combating obesity (9,10). 76 
The evaluation of such interventions would require a reliable imaging biomarker to 77 
quantify BAT. As a result there has been resurgence in interest in BAT imaging. 78 
Positron-emission tomography with computed tomography (PET/CT) has limitations 79 
as a means of quantifying BAT as it relies on the uptake of the radiolabelled tracer 2-80 
deoxy-2-[18F]fluoro-D-glucose (18F-FDG) by metabolically active tissue. 18F-FDG is 81 
taken up to a much lesser degree in metabolically inactive BAT. Consequently BAT 82 
detection on PET/CT is opportunistic, limiting its reproducibility (11), although we 83 
previously reported that the pattern of BAT distribution (when active) remains fairly 84 
consistent across serial PET/CT scans within individuals (12). BAT-specific PET 85 
probes have been developed, including 18F-BODIPY (boron-dipyrromethane), which 86 
show significant accumulation in metabolically active BAT, although uptake in 87 
unstimulated BAT is relatively low (13). 88 
Estimates of BAT prevalence in adult humans varies, but larger studies using 89 
PET/CT report point prevalence of between 1.1% (14) and 8.5% (11), and 5.3% in 90 
our own population (15) – all of which are certainly underestimates. Cumulative 91 
prevalence (based on repeated PET/CT scanning of 145 patients) is estimated at 92 
64% (11), while small dedicated prospective PET/CT studies report point prevalence 93 
as high as 95.8% (16) and 100% (17). However, the high radiation burden, costly 94 
radiotracer and relatively low spatial resolution of PET/CT limit its role as a research 95 
tool in large populations (18). 96 
MRI may offer a non-invasive and safe alternative for BAT quantification, as it can 97 
differentiate between brown and white adipose tissue (WAT) based on differences in 98 
fat (19) and mitochondrial content (20). Therefore MRI has the potential to identify 99 
BAT regardless of its metabolic state (21),  100 
Significantly lower fat fractions (FF) have been reported in BAT than WAT in rodents 101 
(18,19,22-24) and human infants (20,25,26). Human studies have tended to focus on 102 
infants in whom BAT is more prevalent and extensive. Lower BAT FF has been 103 
reported in small numbers of human adults (20,27), although differences decrease 104 
with age (20). We previously reported a case in whom we were able to identify BAT 105 
using MRI, which was subsequently confirmed histologically (28). Gifford et al (29) 106 
identified probable BAT based on FF in two adult humans. For the most part, 107 
however, it has not been possible to extrapolate these findings to prospectively 108 
identify BAT in adult humans solely on the basis of MRI imaging findings. 109 
The aim of this study was to determine whether there was a significant difference in 110 
FF between BAT and WAT in adult humans, and to identify an optimal threshold for 111 
differentiating between these tissues on the basis of FF in vivo. 112 
Our secondary aims were to determine whether FF within BAT and WAT fluctuates 113 
over time. 114 
2. Materials and methods 115 
2.1 Sample 116 
Sixteen volunteers were recruited (mean age 44.2 ± 19.2 years; 9 females, 7 males) 117 
on the basis of showing 18F-FDG standardized uptake values (SUV) >2.5 g/ml within 118 
adipose tissue (i.e. CT attenuation below -100 Hounsfield units) on PET/CT scans 119 
consistent with BAT (‘18F-FDG BAT’). In addition six age ( 5 years) and sex-120 
matched controls were recruited on the basis of showing consistently absent 18F-121 
FDG BAT uptake across serial PET/CT scans (Figure 1). 122 
The PET/CT scans were performed as part of patients’ routine clinical care. 123 
2.2 Ethical approval 124 
Ethical approval was obtained from the Birmingham East, North and Solihull 125 
Research Ethics Committee (NHS REC reference 11/H1206/3). 126 
2.3 PET/CT scanning technique 127 
Scanning was performed on a combined GE Discovery STE PET/CT scanner 128 
(General Electric Medical Systems, Milwaukee, USA). Patients were routinely fasted 129 
for 6 hours prior to scanning. Following administration of 18F-FDG (mean injected 130 
dose 362 MBq, range 103 - 505 MBq), patients rested for 60 minutes within the 131 
PET/CT suite, where ambient temperature was maintained at 24°C. 132 
Emission data were obtained for 3 minutes in each bed position from skull base to 133 
mid thighs, and reconstructed using CT data for attenuation correction. 134 
2.4 MRI scanning technique 135 
Axial 3-point 2D TSE IDEAL (iterative decomposition of water and fat with echo 136 
asymmetry and least-squares estimation) images were acquired on a GE 3T HDxt 137 
MRI scanner (General Electric Medical Systems, Milwaukee, USA) using a quad-138 
channel cardiac receiver coil placed anteriorly across the upper thorax and neck 139 
(slice thickness = 2.5 – 5 mm, repetition time = 440 ms, echo time = 10.7 – 11.1 ms, 140 
acquisition matrix = 512 x 512, number of excitations = 3, and field of view = 300 - 141 
400 mm. 142 
IDEAL fat- and water-only images were post-processed using ImageJ (30) to 143 
generate FF maps according to the formula: 144 
𝐹𝑎𝑡 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 =
𝐹𝑎𝑡 𝑜𝑛𝑙𝑦
𝐹𝑎𝑡 𝑜𝑛𝑙𝑦 + 𝑊𝑎𝑡𝑒𝑟 𝑜𝑛𝑙𝑦
 145 
2.5 Image analysis 146 
Non-fatty tissues were excluded from analysis by thresholding FF maps with a lower 147 
limit set at 50% FF. PET/CT scans were registered to the MRI scans using Mirada 148 
XD 3.4 image fusion software (Mirada Medical Ltd, Oxford, UK) using both rigid and 149 
non-rigid registration techniques, with manual placement of fiducial markers as 150 
necessary.  151 
Two methods of BAT segmentation were then performed, illustrated in Figure 2: 152 
1. Transposition from PET/CT: ROIs were drawn around 18F-FDG BAT deposits 153 
semi-automatically by defining iso-contours set at a standardized uptake 154 
value (SUV) of 2.5 g/ml on the PET/CT scan, which we felt provided the best 155 
compromise between capturing the extent of 18F-FDG uptake within BAT , 156 
whilst minimizing artefactual bleeding into adjacent tissue. These ROIs were 157 
then transposed onto the co-registered FF map. 158 
2. Regional segmentation of supraclavicular fat: BAT, when active on PET/CT, 159 
most likely occurs within the supraclavicular fossa (12,31). Therefore to 160 
determine whether BAT could be identified without the benefit of a priori 161 
knowledge from PET/CT scans, ROIs were drawn freehand around fat in the 162 
supraclavicular fossa on contiguous slices. Morphological edge erosion was 163 
then applied to minimize edge effects from adjacent tissue interfaces using 164 
the ‘eroded range limited’ technique described by Lundström et al (32,33). 165 
For comparison ROIs were manually defined in dorsal subcutaneous WAT on MRI 166 
FF maps. 167 
2.6 Statistical analysis 168 
Differences in mean FF for transposed BAT and WAT were compared on a slice-by-169 
slice basis using analysis of variance (ANOVA) with Bonferroni’s post hoc test for 170 
pairwise comparisons using GraphPad Prism 7.00 for Mac OS (GraphPad Software, 171 
La Jolla, California, USA). Significance was defined as p < 0.05. 172 
Receiver operating characteristic (ROC) curves were generated to plot true positivity 173 
rate (sensitivity) against false positivity rate (1-specificity) for various FF cut-off 174 
points. Area under the curve (AUC), a measure of the accuracy of the test, was 175 
derived, and optimal thresholds for differentiating BAT and WAT calculated using 176 
Youden’s J statistic (34). 177 
Temporal changes in mean FF for BAT and WAT across serial scans (12 scans in 6 178 
subjects; A, D, E, F, I and K) were compared using one-way ANOVA, with 179 
Bonferroni’s post test. 180 
Differences in mean FF between subjects with and without evidence of BAT on 181 
PET/CT (subjects K-V) were compared using two-way ANOVA with Bonferroni’s post 182 
hoc analysis, and ANCOVA to control for differences in baseline WAT FF and mean 183 
daily temperature. ANCOVA analysis was performed on IBM SPSS Statistics for 184 
Macintosh, version 24.0 (IBM Corp., Armonk, N.Y., USA). 185 
3. Results 186 
3.1 Demographics 187 
Twenty-two participants were recruited; 16 with evidence of BAT on PET/CT, and 6 188 
age-and sex matched controls without evidence of BAT activity on multiple PET/CT 189 
scans. 190 
The mean age of participants with BAT activity on PET/CT was 44.3  19.3 years at 191 
initial scanning (Table 1). Nine were female (56.3%) and seven male. 192 
For subjects with BAT activity on PET/CT (subjects A-P) there was a statistically 193 
significant difference in FF between males and females for both subcutaneous WAT 194 
(0.767  0.058 and 0.817  0.037 respectively; p < 0.001) and transposed BAT 195 
(0.669  0.065 and 0.778  0.061; p < 0.001). 196 
FF within subcutaneous WAT showed no correlation with body mass index (r = 197 
0.10).  198 
3.2 Difference in FF between subcutaneous WAT and transposed BAT 199 
One-way analysis of variance showed a statistically significant difference in FF 200 
between transposed BAT and subcutaneous WAT, F(31, 560) = 60.03, p < 0.001. 201 
Post hoc Bonferroni‘s test for multiple comparisons (Table 2) showed FF to be 202 
statistically significantly lower in transposed BAT than subcutaneous WAT in 10/16 203 
subjects (62.5%), and higher in a single subject (E, Figure 3). 204 
3.3 Receiver operating analysis to determine an optimal threshold to 205 
differentiate transposed BAT and subcutaneous WAT 206 
The optimal cut-off to separate transposed BAT and subcutaneous WAT varied 207 
considerably between subjects (Table 3), ranging from 0.681 to 0.853. 208 
There was also considerable variation between subjects in the accuracy of these 209 
optimal FF cut-offs (area under the curve [AUC] 0.248 – 0.924), resulting in wide 210 
variation in sensitivity (0.264 – 0.844) and specificity (0.616 – 0.986). Tissue 211 
separation was excellent or good in 4 subjects (B, C, D and F, i.e. AUC > 0.8), fair in 212 
2 (M and N, i.e. AUC 0.7 - 0.8), and poor in 10 subjects (i.e. AUC < 0.7, Figure 3). 213 
3.4 Temporal FF changes in subcutaneous WAT and transposed BAT 214 
One-way ANOVA for the six subjects who had repeat MRI scans showed a 215 
statistically significant difference in FF between initial and subsequent MRI scan for 216 
both subcutaneous WAT and transposed BAT, F(23, 250) = 39.44, p < 0.0001. Post-217 
hoc analysis with Bonferroni’s test for multiple comparisons (Table 4) showed a 218 
statistically significant temporal change in FF for transposed BAT in subject I (p = 219 
0.0003), and for subcutaneous WAT in subject D (p < 0.0001). The remainder 220 
showed no significant difference in FF for either transposed BAT or subcutaneous 221 
WAT between serial MRI scans (Table 4 and Figure 5). 222 
3.5 Characterisation of subcutaneous WAT and supraclavicular fat 223 
For the subgroup of age-and sex-matched subjects (K-V), FF within supraclavicular 224 
fat was compared against subcutaneous WAT using two-way ANOVA to determine 225 
whether BAT status (i.e. presence or absence of BAT activity on PET/CT) affected 226 
FF. 227 
There was a statistically significant interaction between the effects of tissue type (i.e. 228 
supraclavicular fat and subcutaneous WAT) and BAT status on PET/CT on FF, F(11, 229 
616) = 13.93, p < 0.0001, p2 = 0.024. Simple main effects analysis showed a 230 
statistically significant difference in FF between supraclavicular fat and WAT, F(11, 231 
616) = 467.9, p < 0.0001, p2 = 0.792. There was also a significant (albeit small) 232 
difference in FF between subjects with and without BAT activity on PET/CT F(1, 616) 233 
= 579.5, p < 0.0001, p2 = 0.089. Post hoc Bonferroni’s test for multiple comparisons 234 
showed FF within supraclavicular fat was significantly lower than WAT in all but one 235 
case (Figure 6). 236 
To evaluate differences in supraclavicular fat FF between subjects with (K-P) and 237 
without BAT activity (Q-V) on PET/CT, whilst controlling for variation in both baseline 238 
subcutaneous WAT FF and environmental temperature, a one-way ANCOVA was 239 
performed with baseline subcutaneous WAT FF and mean daily temperature as 240 
covariates. 241 
There was a significant effect of PET/CT BAT status on FF after controlling for WAT 242 
FF and temperature, F(1,316) = 12.537, p < 0.001, although the effect size was 243 
small (p2= 0.038). Mean FF within supraclavicular fat was significantly lower in 244 
subjects with BAT activity on PET/CT (corrected mean FF 0.739, 95% CI 0.734 – 245 
0.743) than those without BAT activity on PET/CT (0.750, 95% CI 0.746 – 0.755), 246 
although the differences were small (corrected mean difference 0.011, 95% CI 0.005 247 
– 0.018). 248 
The predicted main effect of subcutaneous WAT FF upon supraclavicular fat FF was 249 
statistically significant [F(1,316) = 948.455, p < 0.005, p2 = 0.750], as was mean 250 
daily temperature [F(1,316) = 26.723, p < 0.005, p2 = 0.078]. 251 
4. Discussion 252 
In this study, a retrospective analysis of MRI scans, we sought to differentiate 253 
between BAT and WAT in adult humans on the basis of differences in FF, and 254 
whether this fluctuated within individuals over time. We also sought to determine 255 
whether there was a difference in FF within the supraclavicular fossae (the area 256 
most likely to contain BAT) between individuals with and without evidence of BAT on 257 
PET/CT. 258 
Mean FF was statistically significantly lower within BAT than subcutaneous WAT (as 259 
determined by one-way ANOVA) in 10 out of 16 subjects. A single subject showed a 260 
significantly higher FF within BAT (subject E), although this may be a spurious as the 261 
WAT FF (0.596) is unusually low. Although subject E’s BMI was within the normal 262 
range (25.2 kg/m2), they had a muscular body habitus and consequently the volume 263 
of subcutaneous fat was low which may make it susceptible to measurement error or 264 
volume averaging artefact. We observed no significant correlation between BMI and 265 
subcutaneous WAT FF. 266 
This accords with findings from other studies which have shown lower FF within BAT 267 
using Dixon chemical-shift techniques (35) and spectroscopy (36). The lower fat 268 
content within BAT may be attributed to morphological differences between BAT and 269 
WAT adipocytes (37,38). 270 
Studies evaluating BAT on MRI in humans have tended to focus on infants in whom 271 
BAT is more extensive, with far fewer studies involving adults. Although these show 272 
FF to be significantly lower in BAT than WAT the difference diminishes with age; FF 273 
within BAT tends to be lower in infants (24,26) than adults (20,33,39). 274 
There was considerable variation in both BAT and WAT FF between individuals, and 275 
as a result the optimal FF to differentiate BAT and WAT varied between 0.681 and 276 
0.853. Using these heuristic thresholds to identify BAT produced variable results 277 
between subjects, with high accuracy in 4 subjects, moderate in 2, and poor 278 
accuracy in 10. Therefore, a single FF to differentiate BAT from WAT could not be 279 
identified. 280 
For the second element of the study, a subset of six subjects underwent a second 281 
MRI scan to determine whether FF changed over time. Comparison of the two MRI 282 
scans using ANOVA revealed a significant difference in mean BAT FF between 283 
scans, although post hoc tests showed that the change in mean BAT FF was only 284 
statistically significant in a single subject. Similarly the change in mean WAT FF 285 
between scans was only statistically significant in a single subject. 286 
In situ BAT has been identified in rodents in both active (40) and inactive states 287 
(18,23,41). FF within BAT has been shown to fluctuate with functional status 288 
however, with significantly lower BAT FF reported in rats exposed to cold (50.9% at 289 
16°C) than those kept warm (79.4% at 30°C) (42). A similar trend towards lower BAT 290 
FF at low temperatures has also been reported in adult humans (27,43). Lower lipid 291 
content has been described within activated BAT (44) which has been attributed to 292 
depletion of lipid stores (45). 293 
In this study the mean interval between MRI scans was fairly short (1.7 ± 1.1 294 
months), which may be insufficient to capture seasonal differences in BAT activation. 295 
Therefore it may be preferable to perform follow-up scans after 6 or 9 months. Franz 296 
et al (46) demonstrated that even in subjects with BAT activity on PET, the FF within 297 
supraclavicular fat remained stable across multiple MRI scans, albeit in a paediatric 298 
population. 299 
In the third element of the study we compared FF within supraclavicular fat in 6 300 
subjects with BAT uptake on PET/CT, and 6 age- and sex matched controls. We 301 
found that FF within supraclavicular fat was statistically significantly lower than 302 
subcutaneous WAT, which accords with the findings of Franz et al (46) albeit in a 303 
paediatric population. This difference was evident on both subjects with and without 304 
BAT activity on PET/CT, although there was a small statistically significant difference 305 
in supraclavicular FF between the two groups. WAT FF was the greatest factor 306 
influencing FF within supraclavicular fat, accounting for 75% of the variance. 307 
Controlling for baseline differences in WAT FF and mean daily temperature, a 308 
statistically significant difference in mean supraclavicular FF persisted between the 309 
groups, although the effect size was small (mean difference in FF 0.011, 95% CI 310 
0.005 – 0.018) accounting for only 3.8% of variance. This small effect size may be 311 
due to the fact that even in subjects with BAT, supraclavicular fat is largely 312 
composed of WAT, which will increase the mean FF. 313 
It is worthy of note that the mean FF between subjects K to P differed between the 314 
‘transpositional’ and ‘regional’ techniques of the study. This is due to analyses being 315 
performed on different slices on the MRI scan, as BAT or supraclavicular fat depots 316 
were compared with WAT on contiguous slices a slice-by-slice basis. Nonetheless 317 
there was no significant difference in subcutaneous WAT FF between the 318 
techniques. 319 
We are aware of several limitations to this study. Fat quantification based on a TSE 320 
acquisition may be biased due to T2 lengthening due to the removal of J-coupling-321 
induced de-phasing by rapid application of the refocusing pulse (47). Therefore 322 
gradient-echo acquisitions may be more sensitive in detecting small differences 323 
between brown and white adipose tissue. 324 
It is noteworthy that although slice thickness was not uniform (subjects A-J were 325 
scanned with a slice thickness of 5 mm, whilst subjects K-P and their corresponding 326 
age- and sex-matched controls Q-V were scanned at 2.5 mm), slice thickness did 327 
not have a significant effect upon FF for either transposed BAT (P = 0.31) or 328 
subcutaneous WAT (P = 0.96). 329 
To segment out non-fat on MRI FF maps, we chose a lower threshold of 50% FF 330 
instead of the 40% threshold typically used in other studies. We felt that a threshold 331 
of 40% in adult humans was unnecessarily low, as FF within BAT (and in particular 332 
BAT in adult humans) is typically considerably higher than this. We found that 333 
adopting a higher threshold of 50% fat fraction segmented out more non-fat, without 334 
impacting on FF measurements within BAT. 335 
The first element of the study used ROIs transposed from regions of 18F-FDG uptake 336 
consistent with BAT (18F-FDG BAT) on PET/CT onto MRI scans. BAT is highly 337 
dynamic, therefore uptake will fluctuate between PET/CT scans depending on its 338 
activation state. 18F-FDG uptake within BAT may be activated or inhibited within as 339 
little as an hour before administration of 18F-FDG (48). We identified subjects as 340 
lacking BAT based on sustained absence of BAT activity across serial PET/CT 341 
scans. Although the likelihood of detecting BAT increases the more PET/CT scans 342 
an individual undergoes (15) this does not absolutely exclude the presence of 343 
inactive BAT, and there is still the potential to misclassify subjects as lacking BAT 344 
when it is merely quiescent. Currently, PET/CT represents the best and most widely 345 
accepted technique for imaging BAT, and although there was no cooling procedure 346 
to stimulate BAT, the standardised imaging protocol affords some uniformity across 347 
subjects. Thermography has been used as a means of non-invasively imaging BAT 348 
activity in humans (49) but is confined to imaging BAT in its activated state. 349 
In this study we used subcutaneous WAT as a reference. Whilst it may be more 350 
appropriate to use non-avid fat in the supraclavicular fossae and mediastinum as a 351 
reference, these are areas in which BAT is most likely to occur. As MRI and PET/CT 352 
scans were not performed concurrently, absence of 18F-FDG uptake within specific 353 
sites does not exclude inactive BAT. This limitation would be addressed by 354 
performing PET and MRI scans concurrently, ideally following a period of cold 355 
exposure to stimulate BAT activity. 356 
There was considerable variation in WAT FF between subjects, which accounted for 357 
the majority of variation in BAT FF. FF within subcutaneous fat is not uniform, 358 
showing higher fat saturation in deep subcutaneous tissues than superficially (50). 359 
Furthermore WAT is not metabolically inert, and its composition and morphology 360 
varies with season and diet (51). This inter- and intra-subject variation in WAT FF 361 
may be problematic when using WAT as a comparator. 362 
A further limitation is that the PET/CT and MRI scans were performed on different 363 
dates, often in different seasons. Therefore, it is possible that BAT activation status 364 
differed between the PET and MRI scans. This issue has been addressed in a small 365 
study involving hybrid PET/MRI scanning, which showed correlation between FF on 366 
MRI and areas of BAT on PET (52), albeit only in subjects with intense FDG uptake 367 
within BAT deposits. Furthermore no significant difference in FF was found in 368 
subjects with and without evidence of supraclavicular BAT on PET. 369 
In addition to BAT having a lower FF than WAT, BAT is more heterogeneous due to 370 
the high mitochondrial content of BAT, which in turn shortens T2* time (18). The 371 
higher vascularity within BAT results in enhanced perfusion and oxygen consumption 372 
within BAT; basal oxygen consumption is approximately 300% higher than within 373 
WAT (53) although this does fluctuate with the degree of BAT activity (54). This may 374 
be exploited using arterial spine labelling or blood-oxygen-level dependent (BOLD) 375 
imaging (55). 376 
Accuracy may be improved by adopting a multi-parametric approach in which 377 
multiple MRI sequences are analysed. Identification of BAT based on neural network 378 
based automatic segmentation of multi-parametric MRI has shown high accuracy in 379 
identifying BAT in rats when compared with manual segmentation (56). Although 380 
there was histological and immunohistochemical confirmation, this has yet to be 381 
successfully employed in adult humans. 382 
The development of a reliable and accurate radiological biomarker for identifying and 383 
quantifying BAT is an important prerequisite to developing novel therapies for BAT 384 
modulation. Most studies evaluating FF as a means of identifying BAT in humans 385 
have focussed on children and infants. This study provides valuable insights into the 386 
utility of FF in identifying BAT in adult humans. 387 
5. Conclusions 388 
We found a statistically significant difference in FF between BAT and WAT, although 389 
the optimal threshold to separate BAT and WAT varied between individuals. 390 
An effective cut-off point to separate BAT and subcutaneous WAT was only possible 391 
in a quarter of cases, and consequently a universal cut-off to differentiate these two 392 
tissues on MRI could not be identified on these data. 393 
Similarly, there was also a small but statistically significant difference in 394 
supraclavicular FF between those with and without BAT activity on PET/CT. Further 395 
studies would be required to achieve greater precision, in order that BAT may be 396 
identified on MRI without a priori knowledge of BAT uptake on PET/CT. 397 
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Tables 405 
 406 
Subject Sex Age at first 
scan 
(years) 
BMI at 
first scan 
(kg/m2) 
Diagnosis 
BAT uptake on PET/CT  
A Male 65 22.8 Lymphoma 
B Male 67 20.9 Lung adenocarcinoma 
C Female 65 26.2 Colorectal carcinoma 
D Female 53 25.6 Melanoma 
E Male 26 25.2 Testicular seminoma 
F Male 21 23.1 Hodgkin's lymphoma 
G Male 61 21.4 Gastro-intestinal stromal 
tumour 
H Female 30 22.0 Hodgkin's lymphoma 
I Female 73 31.6 Gastro-intestinal stromal 
tumour 
J Female 27 19.4 Hodgkin's lymphoma 
K Female 24 23.4 Hyperparathyroidism-jaw 
tumour syndrome 
L Female 56 21.9 Mucinous rectal cancer 
M Male 27 19.0 Hodgkin's lymphoma 
N Male 18 20.9 Metastatic teratoma 
O Female 54 26.3 Colorectal cancer 
P Female 41 23.7 Solitary pulmonary nodule 
No BAT uptake on PET/CT  
Q Female 24 20.2 Lymphoma 
R Female 54 21.6 Submandibular gland 
carcinoma 
S Male 29 23.6 Seminoma 
T Male 23 25.9 Hodgkin’s lymphoma 
U Female 59 35.3 Non-Hodgkin’s lymphoma 
V Female 41 24.8 Vaginal carcinoma 
Table 1: Demographics of subjects with BAT activity on PET/CT (n=16) 407 
 408 
 409 
 410 
 411 
 412 
 413 
 414 
Subject WAT FF 
(SD) 
Transposed BAT FF 
(SD) 
Adjusted p value 
A 0.827  0.006 0.750  0.101 0.001 
B 0.823  0.010 0.725  0.051 <0.0001 
C 0.840  0.009 0.703  0.070 <0.0001 
D 0.825  0.014 0.708  0.021 <0.0001 
E 0.596  0.040 0.672  0.061 0.009 
F 0.756  0.012 0.599  0.057 <0.0001 
G 0.787  0.011 0.738  0.028 ns 
H 0.812  0.010 0.785  0.063 ns 
I 0.817  0.007 0.768  0.056 0.0001 
J 0.778  0.016 0.748  0.052 0.026 
K 0.815  0.020 0.798  0.031 ns 
L 0.832  0.006 0.810  0.019 0.0595 
M 0.760  0.017 0.677  0.025 <0.0001 
N 0.739  0.019 0.672  0.047 <0.0001 
O 0.815  0.007 0.814  0.022 ns 
P 0.765  0.018 0.738  0.028 0.0054 
Table 2: WAT and transposed BAT FF on initial MRI scan by subject, ns= not 415 
significant. 416 
 417 
 418 
 419 
 420 
Subject Optimal FF 
cut-off 
AUC (95% CI) 
A 0.810 0.678 (0.651 - 0.705) 
0.705)0.0.705) B 0.801 .842 (0.832 - 0.853) 
C 0.830 0.899 (0.888 - 0.909) 
D 0.800 0.924 (0.921 - 0.926) 
E 0.718 0.248 (0.226 - 0.271) 
F 0.681 0.838 (0.813 - 0.863) 
G 0.748 0.599 (0.586 - 0.611) 
H 0.783 0.560 (0.545 - 0.575) 
I 0.779 0.662 (0.649 - 0.676) 
J 0.732 0.578 (0.568 - 0.588) 
K 0.783 0.500 (0.496 - 0.504) 
L 0.792 0.533 (0.530 - 0.537) 
M 0.749 0.762 (0.757 - 0.765) 
N 0.688 0.710 (0.706 - 0.714) 
O 0.853 0.557 (9.553 - 0.561) 
P 0.712 0.577 (0.572 - 0.581) 
Table 3: Receiver operating statistics (AUC = area under the curve) and 421 
optimal FF for WAT and transposed BAT discrimination for subjects with BAT 422 
activity on PET/CT (subjects A-P) 423 
 424 
 425 
 426 
 427 
 428 
 429 
 430 
 431 
 432 
 433 
Subject Scan 1 Scan 2 Adjusted p value 
Transposed BAT FF   
A 0.750 ± 0.101 0.765 ± 0.051 ns 
D 0.708 ± 0.021 0.730 ± 0.044 ns 
E 0.672 ± 0.061 0.703 ± 0.017 ns 
F 0.599 ± 0.057 0.609 ± 0.043 ns 
I 0.768 ± 0.056 0.818 ± 0.055 0.0003 
K 0.798 ± 0.031 0.819 ± 0.026 ns 
    
WAT FF    
A 0.828 ± 0.006 0.829 ± 0.012 ns 
D 0.825 ± 0.014 0.768 ± 0.016 < 0.0001 
E 0.596 ± 0.040 0.581 ± 0.017 ns 
F 0.756 ± 0.012 0.773 ± 0.004 ns 
I 0.817 ± 0.007 0.818 ± 0.017 ns 
K 0.815 ± 0.020 0.824 ± 0.017 ns 
Table 4: WAT and transposed BAT FF on serial scans (n=6 subjects) 434 
Figures 435 
Figure 1: Flow chart of subjects 436 
Figure 2: Regions of interest on axial FF map. Top: transposed BAT from 437 
PET/CT (red), with manually defined ROIs in subcutaneous WAT (blue), (b) 438 
ROIs within supraclavicular fossae (yellow) 439 
Figure 3: Mean differences in FF between WAT and transposed BAT (with 95% 440 
confidence intervals) for subjects A-P. * = p < 0.05, ** = p < 0.01, *** = p < 0.005, 441 
ns = not significant 442 
Figure 4: Summary receiver operating plot showing the sensitivity and 443 
specificity of the optimal FF cut-off for each subject (green = good/excellent 444 
tissue separation, yellow = fair, red = poor) 445 
Figure 5: Temporal changes in WAT and transposed BAT FF (*** = p < 0.001) 446 
Figure 6: Mean differences in FF between WAT and supraclavicular fat (with 447 
95% CI) by subject ( subjects with BAT activity on PET/CT,  subjects 448 
without BAT activity on PET/CT, ns = not significant, * = p < 0.05, ** = p < 0.01, 449 
*** = p < 0.005) 450 
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